CUSIP 372427401COMGNCAQQ4 2025
11 filings · latest Feb 14, 2022
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Motiv8 Investments LLC | 300 | $0 |
| 4 | Mar 31, 2021 | Commodore Capital LP | 13G | 5.4% | 2.87M | SEC |
| 5 | Feb 16, 2021 | Ubs Oconnor LLC | 13G/A | 3.3% | 1.77M | SEC |
| 6 | Feb 16, 2021 | Citadel Advisors LLC | 13G/A | 6.5% | — | SEC |
| 7 | Feb 12, 2021 | Biotechnology Value Fund L P | 13G/A | 5.3% | 2.79M | SEC |
| 8 | Feb 12, 2021 | Avoro Capital Advisors LLC | 13G | 10.0% | 33.61M | SEC |
| 9 | Jul 31, 2020 | Citadel Advisors LLC | 13G | 6.4% | — | SEC |
| 10 | Feb 14, 2020 | Biotechnology Value Fund L P | 13G/A | 3.2% | 1.53M | SEC |
See the full Schedule 13D/13G history for Genocea Biosciences Inc Com New.
Unlock full history